Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors

Autonomic and Autacoid Pharmacology

Volumn 26, Issue 3, 2006, Pages 275-284

  Hamrouni, A M ^a,b   Gudka, N ^a   Broadley, K J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

Author keywords

GABA; M1muscarinic receptors; McN A 343; Muscarinic toxin MT7; Pirenzepine; Rat duodenum

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ADENOSINE TRIPHOSPHATE; BICUCULLINE; CARBENE; GUANYLATE CYCLASE INHIBITOR; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR AGONIST; N(G) NITROARGININE METHYL ESTER; NITRITE REDUCTASE; PENICILLAMINE; PIRENZEPINE; PURINE P2 RECEPTOR; RECEPTOR BLOCKING AGENT; SURAMIN;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG RESPONSE; DUODENUM; INCUBATION TIME; MALE; MUSCLE RELAXATION; NERVE CELL; NONHUMAN; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING;

(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE; ANIMALS; BICUCULLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENUM; ELAPID VENOMS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; MUSCLE RELAXATION; MUSCLE, SMOOTH; NG-NITROARGININE METHYL ESTER; OXADIAZOLES; PENICILLAMINE; PIRENZEPINE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M1; SURAMIN;

EID: 33745153078     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2006.00353.x     Document Type: Article

References (44)

1. ADEM A. KARLSSON E. ( 1997). Muscarinic receptor subtype selective toxins. Life Sci., 60, 1069 1076.
2. BAILEY S.J. HOURANI S.M.O. ( 1994). Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Br. J. Pharmacol., 112, 219 225.
3. BAUER V. KURIYAMA H. ( 1982). The nature of non-cholinergic non-adrenergic transmission in logitudinal and circular muscles of the guinea-pig ileum. J. Physiol. (Lond.), 332, 375 391.
4. BREDT D.S. HWANG P.M. SNYDER S.H. ( 1990). Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature (Lond.), 347, 768 770.
5. BURNSTOCK G. CAMPBELL G. SATCHELL D. SMYTHE A. ( 1970). Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmacol., 40, 668 688.
6. CALIGNANO A. WHITTLE B.J.R. DI ROSA M. MONCADA S. ( 1992). Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo. Eur. J. Pharmacol., 229, 273 276.
7. CORREIA N.A. CAVALCANTI P.M.S. OLIVEIRA R.B. BALLEJO G. ( 1999). Effect of hydroquinone, hydroxocobalamine and carboxy-PTIO on non-adrenergic non-cholinergic nerve mediated relaxations of the rat duodenum. J. Auton. Pharmacol., 19, 233 240.
8. DAVIES R.H. SCHOLES H.E. VIRDI S. BROADLEY K.J. ( 2001). Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors. J. Pharm. Pharmacol., 53, 487 496.
9. DÖRJE F. RETTENMAYR N.M. MUTSCHLER E. LAMBRECHTHT G. ( 1991). Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens. Eur. J. Pharmacol., 203, 417 420.
10. EGLEN R.M. WHITING R.L. ( 1990). Heterogeneity of vascular muscarinic receptors. J. Auton. Pharmacol., 10, 233 245.
11. EGLEN R.M. KENNY B.A. MICHEL A.D. WHITING R.L. ( 1987). Muscarinic activity of McN-A-343 and its value in receptor classification. Br. J. Pharmacol., 90, 693 700.
12. ELTZE M. ( 1988). Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur. J. Pharmacol., 151, 205 221.
13. GARTHWAITE J. SOUTHAM E. BOULTON C.L. NIELSEN E.B. SCHMIDT K. MAYER B. ( 1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol., 48, 184 188.
14. GIBSON A. TUCKER J.F. ( 1982). The effects of the vasoactive intestinal polypeptide and of adenosine-5-triphosphate on the isolated anococcygeus muscle of the mouse. Br. J. Pharmacol., 77, 97 103.
15. HARVEY A.L. KORNISIUK E. BRADLEY K.N. CERVENANSKY C DURAN R ADROVER M SANCHEZ G JERUSALINSKY D. ( 2002). Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors. Neurochem. Res., 27, 1543 1554.
16. HATA F.T. ISHII T. KANADA A. YAMANO N. KATAOKA T. TAKEUKI T. YAGASAKI O. ( 1990). Essential role of nitric oxide in descending inhibition in the rat proximal colon. Biochem. Biophys. Res. Commun., 172, 1400 1406.
17. IVERSEN H.H. WIKLUND N.P. OLGART C GUSTAFSSON L.E. ( 1997). Nerve stimulation-induced nitric oxide release as a consequence of muscarinic M1 receptor activation. Eur. J. Pharmacol., 331, 213 219.
18. JERUSALINSKY D. KORNISIUK E. ALFARO P. QUILLFELDT J. FERREIRA A. RIAL V.E. DURAN R. CERVENANSKY C. ( 2000). Muscarinic toxins: novel pharmacological tools for the muscarinic cholinergic system. Toxicon, 38, 747 761.
19. KANADA A. HATA F. SUTHAMNATPONG N. MAEHARA T. ISHII T. TAKEUCHI T. YAGASAKI O. ( 1992). Key roles of nitric oxide and cyclic GMP in non-adrenergic and non-cholinergic inhibition in rat ileum. Eur. J. Pharmacol., 216, 287 292.
20. KARLSSON E. RISINGER C. JOLKKONEN M. WERNSTEDT C. ADEM A. ( 1991). Amino acid sequence of a snake venom toxin that binds to the muscarinic acetylcholine receptor. Toxicon, 29, 521 526.
21. KARLSSON E. JOLKKONEN M. MULUGETA E. ONALI P. ADEM A. ( 2000). Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors. Biochimie, 82, 793 806.
22. KENAKIN T.P. ( 1997). Pharmacologic Analysis of Drug-Receptor Interaction, 3rd edn. Raven Press, New York.
23. KENNEDY C. IJZERMAN A. ( 1994). Adenosine and ATP: from receptor structure to clinical application. Trends Pharmacol. Sci., 15, 311 312.
24. KRANTIS A. COSTA M. FURNESS J.B. ORBACH J. ( 1980). γ -Aminobutyric acid stimulates intrinsic inhibitory and excitatory nerves in the guinea-pig intestine. Eur. J. Pharmacol., 67, 461 468.
25. LEFF P. WOOD P.E. O'CONNOR S.E. ( 1990). Suramin is a slowly equilibrating but competitive antagonist at P2X-receptors in the rabbit isolated ear artery. Br. J. Pharmacol., 101, 645 649.
26. LI C.G. RAND M.J. ( 1990). Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur. J. Pharmacol., 191, 303 309.
27. LIANG J. CARSI-GABRENAS J. KRAJEWSKI J. MCCAFFERTY J. PURKERSON S. SANTIAGO M. STRAUSS W. VALENTINE H. POTTER L. ( 1996). Anti-muscarinic toxins from Dendroaspis angusticeps. Toxicon, 34, 1257 1267.
28. MACKAY D. ( 1978). How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated J. Pharm. Pharmacol., 30, 312 313.
29. MAGGI C.A. MANZINI S. MELI A. ( 1984). GABAA receptor mediated relaxation of the rat duodenum by activating intramural non-adrenergic-non-cholinergic neurones. J. Auton. Pharmacol., 4, 77 85.
30. MALLARD N. MARSHALL R. SITHERS A. SPRIGGS B. ( 1992). Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens. Eur. J Pharmacol., 220, 1 10.
31. MANZINI S. MAGGI C.A. MELI A. ( 1985). Further evidence for involvement of adenosine-5-triphosphate in the non-adrenergic non-cholinergic relaxations of the isolated rat duodenum. Eur. J. Pharmacol., 113, 399 408.
32. MARTINS S.R. BICUDO R.B. OLIVEIRA R BALLEJO G. ( 1993). Evidence for the participation of the L-arginine-nitric oxide pathway in neurally induced relaxation of the isolated rat duodenum. Braz. J. Med. Biol. Res., 26, 1323 1335.
33. MARTINS S.L.R. DE OLIVEIRA R. BALLEJO G. ( 1995). Rat duodenum nitrergic-induced relaxations are cGMP-independent and apamin-sensitive. Eur. J. Pharmacol., 284, 265 270.
34. MAX S.I. LIANG J-S. VALENTINE H.H. POTTER L.T. ( 1993). Use of m1-toxin as a selective antagonist of m1 muscarinic receptors. J. Pharmacol. Exp. Ther., 267, 480 485.
35. MICHELETTI R. SCHIAVONE A. ( 1990). Functional determination of McN-A-343 affinity for M1 muscarinic receptors. J. Pharmacol. Exp. Ther., 253, 310 314.
36. MICHELETTI R. SCHIAVONE A. GIACHETTI A. ( 1988). Muscarinic M1 receptors stimulate a nonadrenergic noncholinergic inhibitory pathway in the isolated rat duodenum. J. Pharmacol. Exp. Ther., 244, 680 684.
37. MONCADA S. PALMER R.M.J. HIGGS E.A. ( 1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109 142.
38. NEWBERRY N.R. PRIESTLEY T. ( 1987). Pharmacological differences between two muscarinic responses of the rat superior cervical ganglion. Br. J. Pharmacol., 92, 817 826.
39. POSTORINO A. SERIO R. MULE F. ( 1995). Nitric oxide is involved in non-adrenergic, non-cholinergic inhibitory neurotransmission in rat duodenum. J. Auton. Pharmacol., 15, 65 71.
40. SATCHELL D.M. ( 1981). Nucleotide pyrophosphatase antagonizes responses to adenosine 5′-triphosphate and non-adrenergic, non-cholinergic inhibitory nerve stimulation in the guinea-pig isolated taenia coli. Br. J. Pharmacol., 74, 319 321.
41. SERIO R. MULE F. ADAMO E.B. POSTORINO A. ( 1990). Evidence against purine being neurotransmitters of non-adrenergic, non-cholinergic nerves in rat duodenum. Eur. J. Pharmacol., 182, 487 495.
42. SMITS G.J. LEFEBVRE R.A. ( 1996). ATP and nitric oxide: inhibitory NANC neurotransmitters in the longitudinal muscle-myenteric plexus preparation of the rat ileum. Br. J. Pharmacol., 118, 695 703.
43. SOEDIONO P. BURNSTOCK G. ( 1994). Contribution of ATP and nitric oxide to NANC inhibitory transmission in rat pyloric sphincter. Br. J. Pharmacol, 113, 681 686.
44. VANDERMEERS A. VANDERMEERS-PIRET M. RATHE J. WAELBRÖECK M. ORAS A. KARLSSON E. ( 1995). Purification and sequence determination of a new muscarinic toxin (MT4) from the venom of the green mamba (Dendroaspis angusticeps). Toxicon, 33, 1171 1179.